COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Latest Medical and Laser Therapy

June 13, 2003

Article

Chicago-Reducing the IOP level is the first goal when treating patientswith open-angle glaucoma. The latest research indicates that keeping IOPin check benefits patients by protecting the optic nerve from damage andpreserving the visual field. However, individualized patient treatment todetermine the IOP range that works best to control IOP is the challenge.Stephen A. Obstbaum, MD, discussed setting that range for individual patientsand the most beneficial therapy with a workable risk/benefit ratio-bothof which should meet the ultimate challenge of preserving vision and qualityof life.